NO952824L - Sterile gelsammensetninger for sårbehandling - Google Patents

Sterile gelsammensetninger for sårbehandling

Info

Publication number
NO952824L
NO952824L NO952824A NO952824A NO952824L NO 952824 L NO952824 L NO 952824L NO 952824 A NO952824 A NO 952824A NO 952824 A NO952824 A NO 952824A NO 952824 L NO952824 L NO 952824L
Authority
NO
Norway
Prior art keywords
gel compositions
alginate
aqueous gel
wound treatment
compositions
Prior art date
Application number
NO952824A
Other languages
English (en)
Norwegian (no)
Other versions
NO952824D0 (no
Inventor
Craig Julian Hardy
Charlotte Maria Findlay
Original Assignee
Johnson & Johnson Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical filed Critical Johnson & Johnson Medical
Publication of NO952824D0 publication Critical patent/NO952824D0/no
Publication of NO952824L publication Critical patent/NO952824L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2/06—Hot gas
    • A61L2/07—Steam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0071—Plasticisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
NO952824A 1994-07-18 1995-07-17 Sterile gelsammensetninger for sårbehandling NO952824L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414454A GB2291348B (en) 1994-07-18 1994-07-18 Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol

Publications (2)

Publication Number Publication Date
NO952824D0 NO952824D0 (no) 1995-07-17
NO952824L true NO952824L (no) 1996-01-19

Family

ID=10758502

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952824A NO952824L (no) 1994-07-18 1995-07-17 Sterile gelsammensetninger for sårbehandling

Country Status (14)

Country Link
US (1) US5693624A (fi)
EP (1) EP0693292B1 (fi)
JP (1) JPH08187280A (fi)
KR (1) KR960003732A (fi)
AT (1) ATE209510T1 (fi)
AU (1) AU696405B2 (fi)
BR (1) BR9503349A (fi)
CA (1) CA2153947A1 (fi)
DE (1) DE69524152T2 (fi)
FI (1) FI953453A (fi)
GB (1) GB2291348B (fi)
NO (1) NO952824L (fi)
TW (1) TW443932B (fi)
ZA (1) ZA955607B (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701552D0 (en) * 1997-01-25 1997-03-12 Bristol Myers Squibb Co Multi-dose wound gel
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US6197061B1 (en) * 1999-03-01 2001-03-06 Koichi Masuda In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage
US6046160A (en) * 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
AU2742401A (en) 1999-12-30 2001-07-16 Acrymed Methods and compositions for improved delivery devices
FR2827764B1 (fr) * 2001-07-27 2005-08-19 Oreal Composition, notamment cosmetique, renfermant un steroide et un glycol
AU2002335747B2 (en) * 2001-09-15 2009-01-29 Rush University Medical Center Stratified cartilage tissue and methods to engineer same
US20030165473A1 (en) * 2001-11-09 2003-09-04 Rush-Presbyterian-St. Luke's Medical Center Engineered intervertebral disc tissue
HUP0402300A2 (en) * 2001-12-21 2008-08-28 Coloplast As A wound care device
US20040001878A1 (en) * 2002-06-26 2004-01-01 Deroyal Industries, Inc. Infused wound care dressings
CN1678277B (zh) 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
US20050085749A1 (en) * 2003-10-15 2005-04-21 Kevin Baerwalde Device for therapeutic treatment of foot, heel, and/or like pain
US7745509B2 (en) 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)
DE602005026225D1 (de) * 2004-03-12 2011-03-24 Cipla Ltd Sterilisationsprozess für Steroide
EP1781098B1 (en) 2004-07-30 2015-10-07 Avent, Inc. Antimicrobial devices and compositions
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
CN102894009B (zh) 2004-07-30 2015-08-19 阿文特公司 抗微生物的银组合物
EP1809264B1 (en) 2004-09-20 2016-04-13 Avent, Inc. Antimicrobial amorphous compositions
DE102006001954B4 (de) * 2006-01-16 2013-01-03 Lohmann & Rauscher Gmbh & Co. Kg Antiseptische Alginatzubereitung, Verfahren zu deren Herstellung, sowie deren Verwendung
CA2650998A1 (en) * 2006-03-22 2007-10-25 Cellgentech, Inc. Liquid composition for external application and preparation for external application for treatment of skin ulcer
US8293965B2 (en) 2006-04-28 2012-10-23 Kimberly-Clark Worldwide, Inc. Antimicrobial site dressings
US10232064B2 (en) 2006-10-04 2019-03-19 National Cheng Kung University Method for sterilizing biological materials
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
EP2065046B1 (en) * 2007-11-30 2013-07-31 Kao Corporation Gip secretion inhibitor
US8563799B2 (en) 2008-02-25 2013-10-22 Teikoku Seiyaku Co., Ltd. Wound-covering hydrogel material
GB2460815A (en) 2008-04-04 2009-12-16 Kays Medical A sterilisable gel formulation comprising calcium gluconate
EP2416741B1 (en) * 2009-04-06 2015-03-11 Bender Analytical Holding B.V. In situ gelling alginate systems
KR101781814B1 (ko) 2009-10-26 2017-09-26 닛산 가가쿠 고교 가부시키 가이샤 화장료 및 피부외용제, 그리고 의료용 기기
US8927524B2 (en) * 2010-03-11 2015-01-06 Bender Analytical Holding B.V. Sterile alginate-based aqueous composition for medical use and process for the preparation thereof
US9877871B2 (en) 2010-09-17 2018-01-30 Teikoku Seiyaku Co., Ltd. Method for using hydrogel sheet for treating wound
RU2454242C1 (ru) * 2010-10-12 2012-06-27 Борис Карпович Гаврилюк Способ получения средства для устранения дефектов кожи и лечения ран в виде геля на основе водорастворимых полисахаридов растительного происхождения
WO2011133064A1 (ru) * 2010-10-12 2011-10-27 Gavrilyuk Boris Karpovich Способ получения средства для устранения дефектов кожи и лечения ран в виде геля на основе водорастворимых полисахаридов растительного происхождения
WO2013039380A1 (en) 2011-09-15 2013-03-21 Bender Analytical Holding B.V. Sterile alginate-based aqueous composition for medical use and process for the preparation thereof
CN107106492B (zh) 2014-10-14 2022-07-05 塞缪尔·林奇 用于治疗伤口的组合物
RU2616250C1 (ru) * 2015-12-01 2017-04-13 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ получения биоактивной сорбционно-гелиевой композиции
DE102019216424A1 (de) * 2019-10-24 2021-04-29 Mahle International Gmbh Ölkühlermodul

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
US4391799A (en) * 1980-02-15 1983-07-05 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for treating white phosphorus burn wounds
US4393048A (en) * 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
WO1984000111A1 (en) * 1982-06-24 1984-01-19 Robert Alan Smith Pharmaceutical gel composition
JPS5948413A (ja) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd クリダナクを含有する消炎鎮痛外用剤
US4525348A (en) * 1983-12-19 1985-06-25 Yoshitomi Pharmaceutical Industries, Ltd. Pranoprofen gelled ointment
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
DE3903672C1 (fi) * 1989-02-08 1990-02-01 Lohmann Gmbh & Co Kg
IT1248666B (it) * 1990-05-30 1995-01-26 Fidia Spa Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee
JP3254013B2 (ja) * 1991-09-10 2002-02-04 ジョンソン・アンド・ジョンソン・メディカル・インコーポレイテッド 包帯材料およびその製造方法
GB9209327D0 (en) * 1992-04-30 1992-06-17 Johnson & Johnson Medical Freeze-dried pad
GB9218749D0 (en) * 1992-09-04 1992-10-21 Courtaulds Plc Alginate gels
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol

Also Published As

Publication number Publication date
GB2291348B (en) 1999-01-20
GB9414454D0 (en) 1994-09-07
CA2153947A1 (en) 1996-01-19
KR960003732A (ko) 1996-02-23
JPH08187280A (ja) 1996-07-23
EP0693292B1 (en) 2001-11-28
AU696405B2 (en) 1998-09-10
BR9503349A (pt) 1996-02-27
NO952824D0 (no) 1995-07-17
DE69524152D1 (de) 2002-01-10
GB2291348A (en) 1996-01-24
AU2492895A (en) 1996-02-01
EP0693292A1 (en) 1996-01-24
TW443932B (en) 2001-07-01
DE69524152T2 (de) 2002-05-16
ZA955607B (en) 1997-01-06
FI953453A (fi) 1996-01-19
ATE209510T1 (de) 2001-12-15
US5693624A (en) 1997-12-02
FI953453A0 (fi) 1995-07-17

Similar Documents

Publication Publication Date Title
NO952824D0 (no) Sterile gelsammensetninger for sårbehandling
ES530046A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
DE69534287D1 (de) Bioabbaubare quaternäre Haarbehandlungsmittel
ES2152701T3 (es) Composiciones acuosas desinfectantes y de limpieza.
BR9401241A (pt) Composição aquosa para tratamento de feridas e processo para formar a mesma
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
ES8500931A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
NZ506681A (en) Disinfecting composition
ES2026935T3 (es) Procedimiento de tratamiento de plantas contra las enfermedades bacterianas.
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
AU2979899A (en) Treatment of viral disease in swine
NO910033D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
ES2180527T3 (es) Agente para el tratamiento de enfermedades oseas que contienen el factor basico de crecimiento de los fibroblastos.
KR870008910A (ko) 돼지 이질의 예방 및 치료제
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
SE9001111D0 (sv) Supportive use
ATE132003T1 (de) Sterilisierende zusammensetzung
SE9000300A (fi)
UA41945C2 (uk) Антимікробна композиція "палісан"
UA37377A (uk) Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application